PA

Perceptive Advisors Portfolio holdings

AUM $3.46B
1-Year Est. Return 112.42%
This Quarter Est. Return
1 Year Est. Return
+112.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.67B
AUM Growth
-$155M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$166M
2 +$44.4M
3 +$37.5M
4
CAI
Caris Life Sciences
CAI
+$29.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$19.5M

Top Sells

1 +$104M
2 +$99.9M
3 +$90.2M
4
FOLD icon
Amicus Therapeutics
FOLD
+$80.5M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$42.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSX icon
76
Biodesix
BDSX
$63.6M
$613K 0.02%
108,694
LXEO icon
77
Lexeo Therapeutics
LXEO
$660M
$562K 0.02%
139,835
APYX icon
78
Apyx Medical
APYX
$149M
$338K 0.01%
150,000
KALA icon
79
KALA BIO
KALA
$4.96M
$263K 0.01%
55,227
-222,383
ENSC icon
80
Ensysce Biosciences
ENSC
$6.11M
$193K 0.01%
86,666
RVMDW icon
81
Revolution Medicines Inc Warrant
RVMDW
$4.42M
$65.7K ﹤0.01%
250,000
SRZNW icon
82
Surrozen Inc Warrant
SRZNW
$44.6K
$3.02K ﹤0.01%
166,666
ACRV icon
83
Acrivon Therapeutics
ACRV
$70.5M
-5,360,858
ADPT icon
84
Adaptive Biotechnologies
ADPT
$2.15B
-930,972
EYPT icon
85
EyePoint Pharmaceuticals
EYPT
$959M
-1,537,274
IOVA icon
86
Iovance Biotherapeutics
IOVA
$981M
-12,711,788
IRON icon
87
Disc Medicine
IRON
$3.4B
-150,000
MDGL icon
88
Madrigal Pharmaceuticals
MDGL
$12B
-46,500
MREO
89
Mereo BioPharma
MREO
$283M
-876,961
NBTX
90
Nanobiotix
NBTX
$1B
-105,053
OCUL icon
91
Ocular Therapeutix
OCUL
$2.41B
-915,775
PCVX icon
92
Vaxcyte
PCVX
$6.37B
-706,567
RCKT icon
93
Rocket Pharmaceuticals
RCKT
$330M
-140,726
XBI icon
94
State Street SPDR S&P Biotech ETF
XBI
$6.6B
0
TRAW icon
95
Traws Pharma
TRAW
$15.5M
-421,781
OKUR
96
OnKure Therapeutics
OKUR
$42.4M
-1,004,439
KMTS
97
Kestra Medical Technologies
KMTS
$1.29B
-200,000
ITCI
98
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-786,358
APLT icon
99
Applied Therapeutics
APLT
$31.4M
-860,000
ARGX icon
100
argenx
ARGX
$55.9B
-59,510